MA52337A - Nouveaux analogues d'oxaborole et utilisations de ces derniers - Google Patents

Nouveaux analogues d'oxaborole et utilisations de ces derniers

Info

Publication number
MA52337A
MA52337A MA052337A MA52337A MA52337A MA 52337 A MA52337 A MA 52337A MA 052337 A MA052337 A MA 052337A MA 52337 A MA52337 A MA 52337A MA 52337 A MA52337 A MA 52337A
Authority
MA
Morocco
Prior art keywords
oxaborole
analogues
latest
new
oxaborole analogues
Prior art date
Application number
MA052337A
Other languages
English (en)
Inventor
Paul Alan Glossop
Robert Toms Jacobs
Delphine Françoise Monique Launay
Yang Liu
Charles Eric Mowbray
Stephen John Robinson
Richard J Sciotti
Jason D Speake
Gavin Alistair Whitlock
Original Assignee
Anacor Pharmaceuticals Inc
Us Gov Sec Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc, Us Gov Sec Army filed Critical Anacor Pharmaceuticals Inc
Publication of MA52337A publication Critical patent/MA52337A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA052337A 2017-03-01 2018-03-01 Nouveaux analogues d'oxaborole et utilisations de ces derniers MA52337A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762465294P 2017-03-01 2017-03-01

Publications (1)

Publication Number Publication Date
MA52337A true MA52337A (fr) 2021-03-03

Family

ID=63370509

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052337A MA52337A (fr) 2017-03-01 2018-03-01 Nouveaux analogues d'oxaborole et utilisations de ces derniers

Country Status (4)

Country Link
US (2) US10961261B2 (fr)
EP (1) EP3609504A4 (fr)
MA (1) MA52337A (fr)
WO (1) WO2018160845A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
WO2017155879A1 (fr) 2016-03-07 2017-09-14 Agrofresh Inc. Procédés synergiques d'utilisation de composés de benzoxaborole et de gaz de conservation en tant qu'agent antimicrobien pour les plantes cultivées
US10961261B2 (en) 2017-03-01 2021-03-30 Anacor Pharmaceuticals, Inc. Oxaborole analogs and uses thereof
WO2022043936A1 (fr) 2020-08-31 2022-03-03 Pfizer Inc. Procédés de protection de l'arn
WO2023210792A1 (fr) 2022-04-28 2023-11-02 日本農薬株式会社 Composé hétérocyclique contenant de l'azote ayant un groupe oxime, herbicide agricole/horticole contenant ledit composé et leur utilisation
TR2023001878A1 (tr) * 2023-02-20 2024-08-21 Univ Yeditepe Borun nöronal kaynakli lei̇shmani̇asi̇s hastaliğinin tedavi̇si̇ i̇çi̇n kullanimi
CN118724752B (zh) * 2023-03-29 2025-11-28 重庆博腾制药科技股份有限公司 一种酪氨酸激酶抑制剂中间体、制备方法及其应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05006685A (es) 2002-12-18 2005-12-14 Anacor Pharmaceuticals Inc Antibioticos que contienen complejos de acido borinico y metodos de uso.
CN1829521B (zh) 2003-06-16 2011-01-26 安纳考尔医药公司 耐水解的含硼治疗剂和使用方法
AR049915A1 (es) 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Compuestos con contenido de boro y metodos de uso de los mismos
EP1765360B1 (fr) 2004-06-14 2009-11-11 Anacor Pharmaceuticals, Inc. Utilisations antivirales de complexes d'acide borinique
RU2642628C2 (ru) 2006-02-16 2018-01-25 Анакор Фармасьютикалз, Инк. Бор-содержащие малые молекулы в качестве противовоспалительных средств
BRPI0711155A2 (pt) 2006-05-02 2011-08-23 Anacor Pharmaceuticals Inc terapêuticos contendo boro resistentes hidroliticamente e métodos de uso
BRPI0713010A2 (pt) 2006-06-12 2012-10-09 Anacor Pharmaceuticals Inc compostos para o tratamento de doença periodontal
JO3396B1 (ar) 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
WO2009111676A2 (fr) 2008-03-06 2009-09-11 Anacor Pharmaceuticals, Inc Petites molécules contenant du bore utilisées en tant qu'agents anti-inflammatoires
WO2009115486A1 (fr) * 2008-03-18 2009-09-24 Glaxo Group Limited Dérivés amides de triazole destinés à être utilisés en thérapie
US20100256092A1 (en) 2008-05-12 2010-10-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010027975A1 (fr) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore
WO2010045505A1 (fr) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc Petites molécules contenant du bore en tant qu’agents antiprotozoaires
US9493489B2 (en) 2008-10-15 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
SG172040A1 (en) 2008-12-17 2011-07-28 Anacor Pharmaceuticals Inc Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol
EP2458995A1 (fr) 2009-07-28 2012-06-06 Anacor Pharmaceuticals, Inc. Molécules contenant du bore trisubstitué
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
US20110207701A1 (en) 2009-08-19 2011-08-25 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110124597A1 (en) 2009-09-25 2011-05-26 Anacor Pharmaceuticals, Inc. Boron containing small molecules
WO2011049971A1 (fr) 2009-10-20 2011-04-28 Anacor Pharmaceuticals, Inc. Petites molécules contenant du bore comme agents antiprotozoaires
US8461134B2 (en) 2009-11-11 2013-06-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US8716478B2 (en) 2010-01-27 2014-05-06 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011116348A1 (fr) 2010-03-19 2011-09-22 Anacor Pharmaceuticals, Inc. Petites molécules borées en tant qu'agent anti-protozoaire
DK2613788T3 (en) 2010-09-07 2017-08-07 Anacor Pharmaceuticals Inc BENZOXABOROLD DERIVATIVES FOR TREATMENT OF BACTERIA INFECTIONS
WO2012145734A1 (fr) * 2011-04-22 2012-10-26 The Ohio State University Compositions antileshmaniennes et ses méthodes d'utilisation
AR088669A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos
AR088668A1 (es) 2011-11-21 2014-06-25 Lilly Co Eli Moleculas pequeñas que contienen boro
LT2925757T (lt) * 2012-11-19 2017-12-27 Novartis Ag Junginiai ir kompozicijos, skirti parazitinių ligų gydymui
AP2015008638A0 (en) 2013-02-01 2015-08-31 Anacor Pharmaceuticals Inc Boron-containing small molecules as antiprotozoal agents
US9493490B1 (en) 2013-07-22 2016-11-15 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
US10961261B2 (en) 2017-03-01 2021-03-30 Anacor Pharmaceuticals, Inc. Oxaborole analogs and uses thereof

Also Published As

Publication number Publication date
WO2018160845A1 (fr) 2018-09-07
EP3609504A1 (fr) 2020-02-19
US20200024289A1 (en) 2020-01-23
US11691992B2 (en) 2023-07-04
EP3609504A4 (fr) 2021-03-03
US10961261B2 (en) 2021-03-30
US20210253605A1 (en) 2021-08-19

Similar Documents

Publication Publication Date Title
EP3615574A4 (fr) Constructions reconnaissant spécifiquement le glypicane 3 et utilisations de ces dernieres
EP3625358A4 (fr) Biomarqueurs et utilisations de ces derniers
EP3684366A4 (fr) Ligands crbn et utilisations de ces derniers
MA46180A (fr) Analogues de l'amyline
MA51288A (fr) Analogues d'incrétine et leurs utilisations
MA51287A (fr) Analogues d'incrétine et leurs utilisations
EP3661918A4 (fr) Analogues de 1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidin-3-one
MA46589A (fr) Composés et utilisations de ces derniers
EP3615019A4 (fr) Modulateurs de l'interaction sestrine-gator2 et utilisations de ces derniers
EP3595694A4 (fr) Construction de furtif immunitaire cas9 crispr
EP3607587A4 (fr) Panneau d'affichage
EP3689215A4 (fr) Détermination d'attribut de région
EP3411411A4 (fr) Composés benzopyrazole et analogues de ceux-ci
EP3580241A4 (fr) Anticorps anti-facteur d et utilisations de ces derniers
EP3607053A4 (fr) Lymphocytes t spécifiques d'antigènes et utilisations de ces derniers
EP3368663A4 (fr) Lignées cellulaires exemptes de virus et procédés d'obtention de celles-ci
EP3658560A4 (fr) Modulateurs de la somatostatine et utilisations de ces derniers
EP3347334A4 (fr) Déshydrohalogénation d'hydrochlorofluorocarbones
EP3506254A4 (fr) Structure d'insonorisation
EP3436434A4 (fr) Analogues d'indoline et leurs utilisations
EP3710462A4 (fr) Analogues de brartémicine
EP3585903A4 (fr) Production de caroténoïdes et d'apocaroténoïdes
EP3303366A4 (fr) Dérivés de dolastatine 10 et utilisations de ceux-ci
EP3478078A4 (fr) Mélanges d'alcaloïdes de sébadille et d'azadirachtine et utilisations de ces mélanges
EP3644963A4 (fr) Lubrifiant naturel